The DNA-editing technology developer has raised $10m in addition to the $65m it pulled in from investors including Leaps by Bayer in November.

Lilly Asia Ventures contributed to a $55m round that will support work on Nucleix's early-stage lung cancer biopsy.

CareCentrix, Kaiser Permanente and Nationwide have all returned to take part in a round for the remote care technology provider, lifting its overall funding to $95m.

Fairview Health Services and Ascension Ventures have exited the telehealth software provider, which has been bought by Bright Health Group.

The renal denervation product developer secured more than $20m in a round that included strategic investor BrosMed Medical.

The online pharmacy is set to close a round co-led by Prosus Ventures at a $1.5bn post-money valuation, taking its overall funding past $670m.

Surgical imaging system developer Edda Technology has raised $150m in a round led by SoftBank Vision Fund 2.

The Institut Mérieux-backed genome engineering platform developer has closed its series E round with commitments from new and existing investors.

The Bristol Myers Squibb-backed oncology drug developer ultimately raised nearly $144m in its initial public offering.

Capital Medica, Cyberdyne, Eisai, Financial Agency, Mitsui, Mixi, Opt, NID, Philips, Sompo and Vector all took part in a round for the medical ICT tool developer.